Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maxigesic IV for postoperative pain after bunionectomy
NCT02689063Phase 3Completed
- Sponsor
- AFT Pharmaceuticals
- Start
- Oct 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Combogesic IV in postoperative pain, sponsored by AFT Pharmaceuticals. Started Oct 2016; status: completed.
02
Drugs
Combogesic IV
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02689063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02689063.